News for Aurinia Pharmaceuticals Inc (IKAP.SG)

Aurinia Pharmaceuticals Inc. today announced that members of the executive management team will participate in multiple upcoming investor conferences including the: Cowen 41st Annual virtual... | March 2, 2021

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that members of the executive management team will participate in

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2020 Earnings Conference Call February 24, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President, Investor Relations Peter...

January 26, 2021 (Investorideas.com Newswire) Shares of Aurinia Pharmaceuticals traded 30% higher after the company reported that the U.S. Food and Drug Adminis...

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272 CIK : 00016006...

The FDA has approved Aurinia Pharmaceuticals Inc.'s (AUPH) LUPKYNIS in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis.

(RTTNews) - The FDA has approved Aurinia Pharmaceuticals Inc.'s (AUPH) LUPKYNIS in combination with a background immunosuppressive therapy regimen...

/PRNewswire/ -- The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia...

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ('Aurinia” or the 'Company”) today announced that the U.S. Food and Drug Administration ...

What's moving these stocks in pre-market hours today?.